Publications of Elisabeth Hennes

Binici, A.; Hennes, E.; Koska, S.; Niemann, J. A.; Reich, A.; Pfaff, C.; Sievers, S.; Kahtn, A. S.; Thomas, D.; Ziegler, S. et al.; Watzl, C.; Waldmann, H.: Identification of Natural Killer Cell Enhancers Through Mimicking of the Tumor Microenvironment. Chemistry (2025)

Dötsch, L.; Davies, C.; Hennes, E.; Schönfeld, J.; Kumar, A.; Da Cruz Lopes Guita, C.; Ehrler, J. H.; Hiesinger, K.; Thavam, S.; Janning, P. et al.; Sievers, S.; Knapp, S.; Proschak, E.; Ziegler, S.; Waldmann, H.: Discovery of the sEH Inhibitor Epoxykynin as a Potent Kynurenine Pathway Modulator. Journal of Medicinal Chemistry (2024)

Davies, C.; Dötsch, L.; Ciulla, M. G.; Hennes, E.; Yoshida, K.; Gasper, R.; Scheel, R.; Sievers, S.; Strohmann, C.; Kumar, K. et al.; Ziegler, S.; Waldmann, H.: Identification of a Novel Pseudo-Natural Product Type IV IDO1 Inhibitor Chemotype. Angewandte Chemie, International Edition in English (2022)

Hennes, E.; Lampe, P.; Dötsch, L.; Bruning, N.; Pulvermacher, L.-M.; Sievers, S.; Ziegler, S.; Waldmann, H.: Cell‐Based Identification of New IDO1 Modulator Chemotypes. Angewandte Chemie International Edition 60 (18), pp. 9869 - 9874 (2021)

Hennes, E.; Lampe, P.; Dötsch, L.; Bruning, N.; Pulvermacher, L.-M.; Sievers, S.; Ziegler, S.; Waldmann, H.: Cell-Based Identification of New IDO1 Modulator Chemotypes. Angewandte Chemie 133 (18), pp. 9957 - 9962 (2021)

Cromm, P. M.; Adihou, H.; Kapoor, S.; Vazquez-Chantada, M.; Davey, P.; Longmire, D.; Hennes, E.; Hofer, W.; Küchler, P.; Chiarparin, E. et al.; Waldmann, H.; Grossmann, T. N.: Lipidated stapled peptides targeting the acyl binding protein UNC119. ChemBioChem: A European Journal of Chemical Biology, pp. 1 - 10 (2019)

Kremer, L.; Hennes, E.; Brause, A.; Ursu, A.; Robke, L.; Matsubayashi, H. T.; Nihongaki, Y.; Flegel, J.; Mejdrová, I.; Eickhoff, J. et al.; Baumann, M.; Nencka, R.; Janning, P.; Kordes, S.; Schöler, H. R.; Sterneckert, J.; Inoue, T.; Ziegler, S.; Waldmann, H.: Discovery of the Hedgehog Pathway Inhibitor Pipinib that Targets PI4KIIIß. Angewandte Chemie, International Edition, pp. 1 - 37 (2019)

Kremer, L.; Hennes, E.; Brause, A.; Ursu, A.; Robke, L.; Matsubayashi , H. T.; Nihongaki, Y.; Flegel, J.; Mejdrová, I.; Eickhoff, J. et al.; Baumann, M.; Nencka, R.; Janning, P.; Kordes, S.; Schöler, H. R.; Sterneckert, J.; Inoue, T.; Ziegler, S.; Waldmann, H.: Discovery of the Hedgehog Pathway Inhibitor Pipinib that Targets PI4KIIIß. Angewandte Chemie, pp. 1 - 37 (2019)

Hennes, E.: Identification of small-molecule modulators that enhance the ability of the immune system to eliminate cancer cells. Dissertation, TU Dortmund, Dortmund (2022)

Hennes, E.: Validierung der Lipidkinase PI4KB als Zielprotein von Thienopyrimidin‐basierten Inhibitoren des Hedgehog‐Signalwegs. Master, Technische Universität Dortmund, Dortmund (2017)